NRx Pharmaceuticals (NRXP)
Develops NMDA-pathway CNS therapies alongside a majority-owned interventional-psychiatry clinic network.
$3.15
vs last close−0.17 (−5.01%)
Something off on this page? Send us feedback.
Next report
Nov 13, 26
in 51 days
EPS estimate
−$0.26
Revenue estimate
$1.3M
Fiscal quarter
Q3 FY26
EPSReportedEstimate
Mar '25May '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported−$0.72−$0.34−$0.98−$0.27$0.19−$0.04−$0.44Pending
Estimate−$0.20−$0.30−$0.15−$0.11−$0.09−$0.05−$0.11−$0.26
Surprise−262.2%−13.3%−552.7%−145.5%+311.1%+20.0%−312.5%—
RevenueReportedEstimate
Mar '25May '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported$4.0K$2.3M—$242.0K$983.0K$1.1M$1.1MPending
Estimate$5.0M—$3.5M$6.1M$7.5M$19.4M$1.3M$1.3M
Surprise−99.9%——−96.0%−86.9%−94.5%−17.2%—
HistoryUpcoming
| Date / Period | Estimate | Reported | Surprise |
|---|---|---|---|
| Sep 2029 | $4.40 | — | — |
| Jun 2029 | $4.41 | — | — |
| Mar 2029 | $4.24 | — | — |
| Dec 2028 | $5.69 | — | — |
| Sep 2028 | $5.47 | — | — |
| Jun 2028 | $5.48 | — | — |
| Mar 2028 | $5.27 | — | — |
| Dec 2027 | −$0.07 | — | — |
| Sep 2027 | −$0.09 | — | — |
| Jun 2027 | −$0.12 | — | — |
| Mar 2027 | −$0.16 | — | — |
| Dec 2026 | −$0.25 | — | — |
| Nov 2026 | −$0.26 | — | — |
| Aug 2026 | −$0.11 | −$0.44 | −312.5% |
| May 2026 | −$0.05 | −$0.04 | +20.0% |
| Mar 2026 | −$0.09 | $0.19 | +311.1% |
| Nov 2025 | −$0.11 | −$0.27 | −145.5% |
| Aug 2025 | |||
| May 2025 | |||
| Mar 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Mar 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Mar 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Mar 2022 | |||
| Nov 2021 | |||
| Aug 2021 | |||
| May 2021 | |||
| Apr 2021 | |||
| Nov 2020 | |||
| Aug 2020 | |||
| May 2020 | |||
| Mar 2020 | |||
| Nov 2019 | |||
| Aug 2019 | |||
| May 2019 | |||
| Mar 2019 | |||
| Nov 2018 | |||
| Aug 2018 | |||
| May 2018 | |||
| Mar 2018 |
| Date / Period | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Sep 2029 | $4.40 | — | — | $557.2M | — | — | — |
| Jun 2029 | $4.41 | — | — | $557.2M | — | — | — |
| Mar 2029 | $4.24 | — | — | $534.9M | — | — | — |
| Dec 2028 | $5.69 | — | — | $297.3M | — | — | — |
| Sep 2028 | $5.47 | — | — | $285.9M | — | — | — |
| Jun 2028 | $5.48 | — | — | $285.9M | — | — | — |
| Mar 2028 | $5.27 | — | — | $274.4M | — | — | — |
| Dec 2027 | −$0.07 | — | — | $106.1M | — | — | — |
| Sep 2027 | −$0.09 | — | — | $92.3M | — | — | — |
| Jun 2027 | −$0.12 | — | — | $57.6M | — | — | — |
| Mar 2027 | −$0.16 | — | — | $23.2M | — | — | — |
| Dec 2026 | −$0.25 | — | — | $2.9M | — | — | — |
| Nov 13, 2026 | −$0.26 | — | — | $1.3M | — | — | — |
| Aug 17, 2026 | −$0.11 | −$0.44 | −312.5% | $1.3M | $1.1M | −17.2% | +4.9% |
| May 15, 2026 | −$0.05 | −$0.04 | +20.0% | $19.4M | $1.1M | −94.5% | +2.2% |
| Mar 23, 2026 | −$0.09 | $0.19 | +311.1% | $7.5M | $983.0K | −86.9% | −4.3% |
| Nov 17, 2025 | −$0.11 | −$0.27 | −145.5% | $6.1M | $242.0K | −96.0% | −15.3% |
| Aug 18, 2025 | |||||||
| May 15, 2025 | |||||||
| Mar 17, 2025 | |||||||
| Nov 14, 2024 | |||||||
| Aug 14, 2024 | |||||||
| May 14, 2024 | |||||||
| Mar 29, 2024 | |||||||
| Nov 13, 2023 | |||||||
| Aug 14, 2023 | |||||||
| May 16, 2023 | |||||||
| Mar 30, 2023 | |||||||
| Nov 14, 2022 | |||||||
| Aug 15, 2022 | |||||||
| May 16, 2022 | |||||||
| Mar 31, 2022 | |||||||
| Nov 16, 2021 | |||||||
| Aug 16, 2021 | |||||||
| May 20, 2021 | |||||||
| Apr 1, 2021 | |||||||
| Nov 16, 2020 | |||||||
| Aug 14, 2020 | |||||||
| May 15, 2020 | |||||||
| Mar 30, 2020 | |||||||
| Nov 14, 2019 | |||||||
| Aug 14, 2019 | |||||||
| May 15, 2019 | |||||||
| Mar 15, 2019 | |||||||
| Nov 8, 2018 | |||||||
| Aug 8, 2018 | |||||||
| May 15, 2018 | |||||||
| Mar 23, 2018 |